Clinical Trial Update: Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of sunitinib malate in patients with previously untreated metastatic clear cell renal cell carcinoma (stage IV) has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Cancer

Drugs mentioned

• Sunitinib malate (sunitinib malate)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-08-16